Report

STAT+: Coming readout of Kymera eczema trial is a high-stakes moment in a bid to rival Dupixent

Report from the trade press

Headline as published by STAT on Nov 2, 2026; collected by the wire Nov 2, 2026, 5:00 AM ET.

Read at STAT

Coverage

  1. STAT Trade and industry press

    STAT+: Coming readout of Kymera eczema trial is a high-stakes moment in a bid to rival Dupixent

Named in this story

Topics

Explore the named firms, organizations and MDL dockets above. Sources and method

MDL No. 3180

Dupixent

IN RE: Dupixent (Dupilumab) Products Liability Litigation

Transferee judge
Zahid N. Quraishi
Court
District of New Jersey
Actions pending
38

Per the JPML pending-dockets report of October 1, 2026.